PRM-151 therapy well tolerated in patients with advanced myelofibrosis
A study that investigated the potential of the compound PRM-151 (PRM) for reducing progressive bone marrow fibrosis (scarring) in patients with advanced myelofibrosis has shown initial positive results. Myelofibrosis is a ...
Dec 8, 2014
0
0